6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Altamira Therapeutics Ltd.
Filed: May 8, 2019
Period of Report: May 8, 2019
Accession Number: 0001213900-19-008074

View Document ↗ View on SEC.gov ↗